Sign In
Buy BAX
$23.35
+1.20 (+5.42%)
At Close: Jul 16, 2026
AbbVie vs Baxter: One Golden Cross Is Real, One Is a Trap
07:45am, Wednesday, 15'th Jul 2026
Both AbbVie (NYSE:ABBV | ABBV Price Prediction) and Baxter International (NYSE:BAX) flashed the same technical signal this month: a golden cross, where the 50-day moving average pushed above the 200-d
Baxter to Host Second-Quarter 2026 Financial Results Conference Call for Investors
04:10pm, Thursday, 09'th Jul 2026
DEERFIELD, Ill.--(BUSINESS WIRE)--Baxter International Inc. (NYSE:BAX), a leading global medtech company, will host a conference call to discuss its second-quarter 2026 financial results on Thursday,
Baxter Publishes 2025 Sustainability Report Highlighting Refreshed Strategy, Ongoing Commitment to Drive Meaningful Impact
10:00am, Monday, 22'nd Jun 2026
Baxter International Inc. (NYSE: BAX), a global medtech leader, today published its newly renamed [url="]2025 Sustainability Report[/url], highlighting the comp
Baxter Publishes 2025 Sustainability Report Highlighting Refreshed Strategy, Ongoing Commitment to Drive Meaningful Impact
09:00am, Monday, 22'nd Jun 2026
DEERFIELD, Ill.--(BUSINESS WIRE)--Baxter International Inc. (NYSE:BAX), a global medtech leader, today published its newly renamed 2025 Sustainability Report, highlighting the company's progress and r
Baxter's Unit Synovis MCA to Lead Global Rollout of the SHIYA Platform
11:25am, Friday, 19'th Jun 2026
BAX gains as Synovis MCA signs a multi-year deal to commercialize MediThinQ's SHIYA 3D surgical visualization platform worldwide.
Reasons to Retain Baxter International Stock in Your Portfolio for Now
03:16pm, Tuesday, 16'th Jun 2026
BAX is pursuing a broad turnaround as innovation, resilient demand, and AI integration support recovery despite regulatory risks and margin pressure.
Baxter International Inc. (BAX) Presents at Goldman Sachs 47th Annual Global Healthcare Conference 2026 Transcript
02:42pm, Tuesday, 09'th Jun 2026
Baxter International Inc. (BAX) Presents at Goldman Sachs 47th Annual Global Healthcare Conference 2026 Transcript
Baxter International Inc. (BAX) Presents at Bank of America Global Healthcare Conference 2026 Transcript
04:40pm, Wednesday, 13'th May 2026
Baxter International Inc. (BAX) Presents at Bank of America Global Healthcare Conference 2026 Transcript
Baxter International Shareholders Approve Board Slate, Pay and Incentive Plan at Annual Meeting
09:06pm, Saturday, 09'th May 2026
Baxter International NYSE: BAX held its 2026 annual meeting of stockholders by webcast, with shareholders giving preliminary approval to all five proposals presented by the company, including the elec
Baxter International Still Has A Path To Upside
10:30pm, Thursday, 07'th May 2026
In recent years, stocks like Baxter International have underperformed: most low-growth, high-debt, struggling names have been bad investments at basically any price. Concerns are real, and early misst
Madison Small Cap Fund Q1 2026 Portfolio Activity
10:35pm, Monday, 04'th May 2026
ICU Medical's new high-volume pump has more connected features, which we believe will drive retention rates and incremental revenue. SiteOne Landscape Supply controls 18% of this $26 billion industry
Baxter International Inc. (BAX) Q1 2026 Earnings Call Transcript
03:51pm, Thursday, 30'th Apr 2026
Baxter International Inc. (BAX) Q1 2026 Earnings Call Transcript
BAX Stock Gains on Q1 Earnings & Sales Beat, Margins Contract
11:45am, Thursday, 30'th Apr 2026
Baxter beats Q1 earnings and revenue estimates, sending shares higher despite declining profits and margin contraction.
Baxter (BAX) Q1 Earnings: Taking a Look at Key Metrics Versus Estimates
11:30am, Thursday, 30'th Apr 2026
The headline numbers for Baxter (BAX) give insight into how the company performed in the quarter ended March 2026, but it may be worthwhile to compare some of its key metrics to Wall Street estimates
Baxter International (BAX) Tops Q1 Earnings and Revenue Estimates
09:30am, Thursday, 30'th Apr 2026
Baxter International (BAX) came out with quarterly earnings of $0.36 per share, beating the Zacks Consensus Estimate of $0.31 per share. This compares to earnings of $0.55 per share a year ago.
